基质金属蛋白酶及其抑制剂与肝癌关系的研究进展

赵玮; 宣世英; 孙樱

基质金属蛋白酶及其抑制剂与肝癌关系的研究进展

1. 青岛市传染病医院
2. 青岛市市立医院

详细信息

中图分类号: R735.7
计量
- 文章访问数: 3353
- HTML全文浏览量: 11
- PDF下载量: 1417
- 被引次数: 0
出版历程
- 出版日期: 2008-02-20

摘要

HTML全文

参考文献(17)

[1]Lynch C C, Matrisian LM.Matrix metalloproteinases in tumor-hostcell communication[J].Differentiation, 2002, 70 (9-10) ∶561-573.

[2]Alper O, Bergmann-Leitner E S, Bennett T A, et al.Epidermalgrowth factor receptor signaling and the invasive phenotype of ovariancarcinoma cells[J].J Natl Cancer Inst, 2001, 93 (18) ∶1375-1384.

[3]Cox G, O'byrne K J.Matrix metalloproteinases and cencer[J].Anti-cancer Res, 2001, 21 (6B) ∶4207-4219.

[4]谢玉梅, 聂青和, 周永兴, 等.TIMP-1和TIMP-2在原发性肝癌生长、浸润及转移中的作用[J].胃肠病学和肝病学杂志, 2002, 11 (3) ∶225-228.

[5]Kleiner D E, Stetler-Stevenson WG.Matrix metalloproteinasas andmetastasis[J].Cancer Chemother Pharmacol, 1999, 43 Suppl∶S42-51.

[6]蒋扬富, 杨治华, 胡敬群, 等.血管内皮生长因子和基质金属蛋白酶-9在原发性肝癌中的表达及其临床意义[J].癌症, 2000, 19 (1) ∶17-19.

[7]Bu W, Tang Z Y, Sun F X, et al.Effects of matrixmetalloproteinaseinhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCID20[J].Hepatogastroenterology, 1998, 45 (22) ∶1056-1061.

[8]Kuyvenhoven J P, van Hoek B, Blom E, et al.Assessment of theclinical significance of serum matrix metalloproteinases MMP-2 andMMP-9 in patients with various chronic liver diseases and hepato-cellular carcinoma[J].Thromb Haemost, 2003, 89 (4) ∶718-725.

[9]McKenna G J, Chen Y, Smith R M, et al.Arole for matrix metallo-proteinases and tumor host interaction in hepatocellularcarcinomas[J].Am J Surg, 2002, 183 (5) ∶588-594.

[10]蔡阳, 吴志全, 樊嘉等.膜型基质金属蛋白酶-1与肝细胞癌侵袭转移性的关系[J].中华肝脏病杂志, 2000, 8 (4) ∶236-238.

[11]Martin D C, Fowlkes J L, Babic B, et al.Insulin-like growth fac-torⅡSignaling in neoplastic proliferation is blocked by transgenicexpression of the metalloproteinase inhibitor TIMP-1[J].J Cell Bi-ol, 1999, 146 (4) ∶881-892.

[12]Bergers G, Coussens L M.Extrinsic regulators of epithelial tumorprogression:metalloproteinases[J].Curr Opin Genet Dev, 2000, 10 (1) ∶120-127.

[13]Qi J H, EbrahemQ, Moore N, et al.Anovel function for tissue in-hibitor of metalloproteinases-3 (TIMP-3) :inhibition of angiogene-sis by blockage of VEGF binding to VEGF receptor-2[J].NatMed, 2003, 9 (4) ∶407-415.

[14]Pang I H, Hellberg P E, Fleenor D L, et al.Expression of matrixmetalloproteinases and their inhibitors in human trabecular meshworkcells[J].Invest Ophthalmol Vis Sci, 2003, 44 (8) ∶3485-3493.

[15]陈晓锋, 顾振纶, 梁中琴, 等.基质金属蛋白酶与肿瘤侵袭和转移研究进展[J].中国药理学通报, 2001, 17 (3) ∶253-256.

[16]Fang J, Shing Y, Wiederschain D, et al.Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumormodel[J].Proc Natl Acad Sci USA, 2000, 97 (8) ∶3884-3889.

[17]Kleiner DE, Stetler-Stevenson WG.Matrix metalloproteinasas andmetastasis[J].Cancer Chemother Pharmacol, 1999, 43 Suppl∶S42-51.

施引文献

资源附件(0)

访问统计